Search filters

List of works by Ignace Vergote

'State of the art' of radical hysterectomy; current practice in European oncology centres

scientific article published in February 2004

2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth

scientific article published on November 1, 2003

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

scientific article

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

scientific article

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

scientific article published on 2 October 2017

A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

scientific article

A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

scientific article published on 01 October 2017

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

scientific article published on 01 February 2019

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse

scientific article published on 21 March 2016

A Systematic Review of Estimating Breast Cancer Recurrence at the Population-Level with Administrative Data

scientific article published on 07 April 2020

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium

scientific article published on 3 April 2013

A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.

scientific article published on 27 January 2013

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

scientific article

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model

scientific article published in July 1999

A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples

scientific article

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

scientific article published on 19 September 2010

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

scientific article published on 18 September 2017

A new prognostic model for FIGO stage 1 epithelial ovarian cancer

scientific article published on 07 November 2006

A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study

scientific article published on 9 September 2011

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

scientific article published on 19 June 2020

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

scientific article

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery

scientific article

A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy

scientific article published on 10 September 2011

A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer

scientific article published on September 1990

A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas

scientific article published on 01 January 1990

A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study

scientific article published in March 2004

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

scientific article published on 26 October 2012

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

scientific article published on 23 January 2009

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

scientific article published on 20 September 2012

A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel

scientific article published on 09 December 2019

A randomized trial of adjuvant progestagen in early endometrial cancer

scientific article published on 01 September 1989

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen

scientific article published in July 1998

A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer

scientific article published on 29 November 2019

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

scientific article published on August 1996

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer

scientific article published on 3 November 2017

A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours

scientific article published on May 1, 2003

A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.

scientific article published on December 2003

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

scientific article published on October 1, 1997

A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors

scientific article published on 01 January 2009

A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy

scientific article published on June 2007

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?

scientific article

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

scientific article

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

scientific article published on August 2013

ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients

scientific article published on 19 April 2018

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer

scientific article

Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer

scientific article published on 01 September 2000

Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients

scientific article published in September 2004

Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.

scientific article

Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.

scientific article

Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype

scientific article published on 05 September 2006

Adjuvant therapy for early staged (epithelial) cancer

scientific article published on 01 March 2004

Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view

scientific article published on September 2006

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

scientific article published on 10 July 2016

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

scientific article published on 20 March 2018

Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel

scientific article published on October 11, 2010

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer

scientific article published on 09 August 2007

Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study

scientific article published on 16 June 2015

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).

scientific article

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study

scientific article (publication date: February 2003)

Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium

scientific article published on 21 March 2014

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

scientific article published on 15 June 2017

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D

scientific article published on 21 January 2020

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

scientific article published on 19 March 2013

Anaplastic nodules in an ovarian mucinous tumor. Case report and literature review

scientific article

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

scientific article published on 01 November 2000

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

scientific article published on 17 June 2014

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

scientific article published on 01 July 2019

Application of proteomics in ovarian cancer: which sample should be used?

scientific article published on 06 October 2009

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

scientific article published on 06 April 2012

Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?

scientific article published on 4 December 2013

Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis

scientific article published on 27 January 2011

Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling

scientific article published on 01 September 2006

Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses

scientific article published in January 1999

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

scientific article

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

scientific article published on 26 September 2020

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

scientific article published on 21 June 2016

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

scientific article published in May 2005

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer

scientific article published on June 2005

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

scientific article published on 4 September 2016

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive

scientific article published on 9 February 2008

B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production

scientific article

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

scientific article

Balancing false positives and false negatives for the detection of differential expression in malignancies.

scientific article published on September 2004

Belgian register and reference centers for gestational trophoblastic diseases

scientific article published on November 2015

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.

scientific article

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

scientific article published on 17 March 2014

Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial

scientific article published on 8 May 2017

Bifunctional pathway of uterine carcinosarcomas

scientific article published on 01 March 2003

Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor

scientific article published on June 24, 2008

Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer

scientific article

Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

scientific article published on 06 July 2020

Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age

scientific article published on 09 January 2007

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.

scientific article published on 20 November 2017

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers.

scientific article published on 16 May 2013

Breast cancer subtype and survival by parity and time since last birth.

scientific article published on 10 February 2018

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study

scientific article published on 30 September 2011

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

scientific article published on 12 January 2012

CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma

scientific article published on 26 July 2005

Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes

scientific article published on 19 October 2009

Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study

scientific article published in December 2009

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

scientific article

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

scientific article published on 26 June 2014

Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

scientific article published on 29 April 2020

Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging--preliminary results

scientific article

Cervical neoplasia during pregnancy: diagnosis, management and prognosis

scientific article

Chairperson's introduction: Surgical skills, especially in the upper abdomen, remain pivotal in the treatment of advanced ovarian cancer

scientific article published on 01 September 2011

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)

scientific article published on 29 June 2018

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies

scientific article published on 28 July 2015

Chemotherapy for recurrent cervical cancer

scientific article published on 04 September 2007

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report

scientific article published on 01 August 2016

Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses

scientific article published on 14 November 2016

Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspring

scientific article published on 07 November 2006

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

scientific article published on 16 November 2017

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

scientific article published on 22 September 2015

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923).

scientific article

Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer1

scientific article published in September 2008

Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial

scientific article published on 01 January 2009

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer

article

Clinical Trials in Recurrent Ovarian Cancer

scientific article published on May 1, 2011

Clinical management of uterine sarcomas

scientific article published on December 2009

Clinical outcome after CO₂ laser laparoscopic radical excision of endometriosis with colorectal wall invasion combined with laparoscopic segmental bowel resection and reanastomosis

scientific article

Clinical outcome after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis: a prospective cohort study

scientific article

Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature

scientific article published on February 2009

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer

scientific article

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

scientific article published on 25 September 2007

Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens

scientific article

Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer

scientific article

Combined modality adjuvant therapy for high-risk endometrial cancer

scientific article published on 07 July 2016

Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis

scientific article published on 28 May 2020

Combining conventional therapy with immunotherapy: A risky business?

scientific article published on 06 April 2019

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

scientific article published on 19 June 2015

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

scientific article

Common variants at 19p13 are associated with susceptibility to ovarian cancer

scientific article

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

scientific article

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients

scientific article published on September 27, 2010

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study

scientific article published on 05 December 2020

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

scientific article published on 22 September 2020

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

scientific article published on 29 December 2020

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

scientific article

Controversies regarding tamoxifen and uterine carcinoma

scientific article published on February 1, 1998

Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].

scientific article published on 19 April 2016

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (p

scholarly article published in European Journal of Cancer

Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

scientific article published on 03 November 2020

Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome

scientific article published on 01 December 2001

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease

scientific article published on 08 December 2020

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

scientific article published on 4 November 2016

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium

scientific article published on 28 October 2013

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

scientific article

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging

scientific article

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial

scientific article published on 14 May 2011

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

scientific article published on 04 September 2020

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

scientific article published on February 2011

Dendritic cell immunotherapy in uterine cancer.

scientific article

Dendritic cell-based immunotherapy in ovarian cancer

scientific article

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models

scientific article published on 17 March 2020

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

scientific article published on 19 July 2017

Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.

scientific article published on December 2009

Diet-induced obesity in gravid rats engenders early hyperadiposity in the offspring

scientific article published on October 2007

Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm.

scientific article

Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report

scientific article published on 01 May 2018

Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice

scientific article published in December 1992

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

scientific article published in January 2008

Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?

scientific article published in December 2009

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

scientific article

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

article published in 2003

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.

scientific article published on 18 February 2018

Dysgerminoma of the ovary in association with XY gonadal dysgenesis

scientific article published on March 1983

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

scientific article

EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low

scientific article published on 20 December 2019

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

EORTC-GCG process quality indicators for ovarian cancer surgery

scientific article

EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia

scientific article published on June 2012

ERBB-2 gene overexpression and amplification in uterine sarcomas

scientific article

ESGO statement on cervical cancer vaccination

scientific article published on 01 November 2007

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

scientific article published on 02 May 2019

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

scientific article published on 01 May 2019

EXPRESSION III: Patient´s Expectations and Preferences regarding Physician-Patient Relationship and Clinical Management. Results of the International NOGGO/ENGOT-ov4-GCIG study in 1,830 Ovarian Cancer Patients from European countries.

scientific article published on 5 February 2018

Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer

scientific article published on 11 August 2011

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

scientific article published on 20 November 2018

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

scientific article published on 08 October 2020

Effect of laparoscopic surgery for moderate and severe endometriosis on depression, relationship satisfaction and sexual functioning: comparison of patients with and without bowel resection

scientific article published on 24 June 2013

Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer

scientific article

Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer

scientific article published on 27 September 2020

Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006

scientific article published on 01 September 2006

Endocrine treatment and prevention of breast and gynaecological cancers

scientific article published on 01 November 2002

Endodermal sinus tumor of the vulva: successfully treated with high-dose chemotherapy

scientific article published in September 2004

Endometrial cancer

scientific article published on 01 August 2005

Endometrial cancer: predictors of response and preferred endocrine therapy

scientific article published on September 2006

Endometrial carcinosarcoma with osteoclast-like giant cells.

scientific article

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

scientific article published on 01 August 2005

Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation

scientific article published on October 1, 2003

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature

scientific article

Endometriosis and the development of malignant tumours of the pelvis. A review of literature

scientific article published on April 2004

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

scientific article

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

scientific article published in 2013

Epithelial ovarian cancer

scientific article published on 01 March 2019

Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment

scientific article published in March 2014

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

scientific article

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

scientific article published on 8 April 2016

Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

scholarly article published in Nature Genetics

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.

scientific article published in February 2003

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

scientific article published on 01 April 2010

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groupsand industry partners - a new Model D for drug and medical device development

scientific article published on 12 May 2020

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

scientific article published in September 2015

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

scientific article published on September 2016

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

scientific article published on 01 September 2017

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

scientific article published in May 2017

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

scientific article published on 01 January 2020

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

scientific article published on 17 December 2014

Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study

scientific article published on 25 June 2018

Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study

scientific article published on 4 May 2016

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

scientific article published on February 7, 2012

Evaluation of serum CA 125 level as a tumor marker in borderline tumors of the ovary

scientific article published on 01 September 1993

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

scientific article published on 30 April 2020

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

article

Evolution in Endometrial Cancer: Evidence From an Immunohistochemical Study

scientific article published on 01 February 2011

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

scientific article published on 05 February 2014

Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)

scientific article published on 05 March 2020

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OC

scientific article published on 16 May 2017

Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study

scientific article published in August 2011

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

scientific article published on February 21, 2012

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

scientific article

External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group

scientific article published in August 2007

External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer

scientific article

FIGO Award for Professor Marleen Temmerman

scientific article

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

scientific article published on 9 February 2018

Feasibility of ultrasound-guided percutaneous samplings in the pregnant baboon: a model for studies on transplacental transport

scientific article published on 15 December 2008

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors

scientific article published on 01 October 2016

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

scientific article published on 31 January 2012

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

scientific article published on 19 December 2016

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

scientific article

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

scientific article published on 18 August 2016

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

scientific article published on April 26, 2012

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

scientific article

Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy

scientific article published on April 2, 2013

Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study

scientific article published on 26 June 2007

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

scientific article published on March 2004

Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women

scientific article published in November 2002

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

scientific article published in July 2003

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials

scientific article published in July 2005

Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents

scientific article

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

scientific article published in August 2002

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

scientific article published on 7 September 2016

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers

scientific article

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

scientific article published on April 2013

Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes in ovarian cancer surgery

scientific article published on 01 December 1998

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

scientific article published on 11 September 2006

Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

scientific article published in January 2006

Genetic changes in nonepithelial ovarian cancer

scientific article published on July 2013

Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer

scientific article published on 13 December 2015

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

scientific article

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

scientific article published in September 2016

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

scientific article

Genome-wide association study identifies a common variant associated with risk of endometrial cancer

scientific article

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

scientific article published on 5 November 2013

Genomic aberrations relate early and advanced stage ovarian cancer

scientific article published on 12 May 2012

Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.

scientific article published in June 1998

Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer

scientific article published on 23 September 2017

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

scientific article published on 31 January 2016

Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system

scientific article published on 04 February 2009

Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting

scientific article published on March 2014

Gynecologic cancers in pregnancy: guidelines of an international consensus meeting

scientific article published on May 2009

Gynecologic oncology in pregnancy

scientific article published on 04 March 2008

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

scientific article

HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma.

scientific article

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium

scientific article

HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

scientific article published on 01 August 2018

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

scientific article

HPV induced ovarian squamous cell carcinoma: case report and review of the literature

scientific article published on 28 February 2007

Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).

scientific article published on 30 March 2016

Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer

scientific article published on December 1, 1992

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report

scientific article

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma

scientific article published on 4 December 2012

Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

scientific article published on 5 August 2005

Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?

scientific article published on 23 March 2017

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

article published in 2003

Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer

scientific article published on 01 December 2019

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

scientific article published on January 2013

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

scientific article

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

scientific article published on 12 January 2015

Images in clinical medicine. Tamoxifen-induced endometrial polyp

scientific article published on 01 November 1996

Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium

scientific article published on 9 March 2018

Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes.

scientific article

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

scientific article

Immunohistochemical determination of hormone receptors in uterine adenosarcomas

scientific article published in March 2003

Immunohistochemical expression of CD10 antigen in uterine adenosarcoma

scientific article published on 01 November 2004

Immunological parameters as a new lead in the diagnosis of ovarian cancer

scientific article

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

scientific article published in September 2013

Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma

scientific article published on 01 September 2010

Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course

scientific article published on 21 December 2015

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

article by J Baptist Trimbos et al published 1 January 2003 in Journal of the National Cancer Institute

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

scientific article published on 15 March 2013

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial

scientific article published on 2 October 2014

Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma

scientific article published on 01 April 2004

Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.

scientific article

Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests

scientific article published in January 2011

In Early-Stage Breast Cancer, the Estrogen Receptor Interacts With Correlation Between Human Epidermal Growth Factor Receptor 2 Status and Age at Diagnosis, Tumor Grade, and Lymph Node Involvement

scientific article published on 01 April 2008

In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol

scientific article published on 01 November 2016

In utero exposure to chemotherapy: effect on cardiac and neurologic outcome

scientific article published on 01 April 2006

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy

scientific article published on 01 March 2002

Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors

scientific article published on 13 August 2007

Incorporation of pazopanib in maintenance therapy of ovarian cancer

scientific article

Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer

scientific article published on 01 November 2019

Increased expression of placental growth factor in high-grade endometrial carcinoma

scientific article published on 10 December 2012

Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy

scientific article

Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.

scientific article published on January 2009

Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients

scientific article published on 09 May 2018

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

scientific article published on July 2016

Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma.

scientific article published on 23 April 2018

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

scientific article

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer

scientific article published on 10 April 2019

Interval debulking surgery: an alternative for primary surgical debulking?

scientific article

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers

scientific article published on 2 December 2015

Intraperitoneal antineoplastic agents in the management of ovarian cancer

scientific article published on May 1, 1991

Intraperitoneal chemotherapy in ovarian cancer remains experimental

scientific article published on 01 October 2006

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view

scientific article published on 01 April 2008

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

scientific article

Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group

scientific article published on 05 July 2011

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

scientific article published on December 20, 2011

Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?

scientific article published on 12 August 2019

Is it safe to treat endometrial carcinoma endoscopically?

scientific article published on 5 October 2009

Is there a role for HIPEC in ovarian cancer?

scientific article published on 01 November 2018

Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?

scientific article published in January 2006

Joint ENGOT and GOG Foundation requirements for trials with industry partners

scientific article published on 18 July 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners

scientific article published on 01 August 2019

KitGene in Endometrial Carcinoma: An Immunohistochemical and Mutational Analysis

scientific article published on 01 February 2011

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

scientific article published on 18 June 2013

Laparoscopic hysterectomy for early endometrial cancer

scientific article published on 16 July 2010

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer

scientific article published on January 2002

Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB.

scientific article

Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review

scientific article

Laparoscopy in gynaecologic oncology: a review

scientific article

Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome

scientific article published on 01 March 2007

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

scientific article published on 27 January 2014

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer

scientific article published on 01 October 2003

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

scientific article

Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma

scientific article published on August 2009

Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports.

scientific article

Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.

scientific article

Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients

scientific article

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

scientific article published on 24 October 2018

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

scientific article published on 01 November 2003

Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.

scientific article published on 6 August 2016

Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer

scientific article published on December 29, 2012

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

scientific article published on 24 September 2020

Long-term sexual functioning in women after surgical treatment of cervical cancer stages IA to IB: a prospective controlled study

scientific article published in October 2014

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer

article

Lymph Node Sampling and Taking of Blind Biopsies Are Important Elements of the Surgical Staging of Early Ovarian Cancer

scientific article published on 01 October 2010

Lymphadenectomy in endometrial cancer

scientific article

Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL): reliability and validity.

scientific article

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

scientific article published on 21 August 2020

Management of borderline ovarian neoplasms

scientific article published on July 2007

Management of recurrent endometrioid endometrial carcinoma: an overview

scientific article published on April 2009

Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview

scientific article published on April 2009

Manual lymph drainage may not have a preventive effect on the development of breast cancer-related lymphoedema in the long term: a randomised trial

article

Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of Cancer

scientific article published on 9 December 2003

Meigs' syndrome with elevated serum CA 125 levels: two case reports and review of the literature

scientific article published on December 1995

Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma.

scientific article

Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant

scientific article published on September 2006

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.

scientific article

Microsatellite instability in uterine sarcomas

scientific article

Microsatellite instable and microsatellite stable primary endometrial carcinoma cells and their subcutaneous and orthotopic xenografts recapitulate the characteristics of the corresponding primary tumor

scientific article published in March 2015

Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab

scientific article published on 21 March 2007

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

scientific article published on 15 August 2023

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium

scientific article published in January 2013

Molecular profiling of platinum resistant ovarian cancer: Use of the model in clinical practice

scientific article published on 01 September 2006

Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

scientific article published on 2 March 2016

Morcellation of uterine leiomyomas: a plea for patient triage

scientific article published on 01 November 2015

Morphology and tumor-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival

scientific article published on 07 October 2018

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

scientific article published on April 2013

Multi‐center experience of robot‐assisted laparoscopic para‐aortic lymphadenectomy for staging of locally advanced cervical carcinoma

scientific article published on May 10, 2013

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.

scientific article

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors

scientific article published on 01 November 2019

Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer

scientific article published on September 19, 2011

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.

scientific article published in June 2017

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

scientific article published on 30 June 2009

Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.

scientific article published on 4 June 2015

Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature

scientific article

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Neoadjuvant chemotherapy for ovarian cancer

scientific article

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

scientific article published on 21 September 2012

Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists?

scientific article published on 01 October 2010

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

scientific article

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

scientific article

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

scientific article published on 06 November 2018

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

scientific article

New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography

scientific article published in June 2006

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

scientific article published on September 2016

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

scientific article

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

scientific article published on 28 September 2019

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

scientific article published on 27 September 2016

No association between FTO or HHEX and endometrial cancer risk

scientific article

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

scientific article published in May 2015

Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors

scientific article published on June 2000

Novel therapies, including enzastaurin, in the treatment of ovarian cancer

scientific article published on 22 March 2014

OC04.03: Quantifying the risk of ovarian malignancy prior to surgery based on the IOTA simple rules

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

scientific article

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

scientific article published on 27 March 2012

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

scientific article published on 08 April 2016

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)

scientific article published on 20 November 2019

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

scientific article published on January 12, 2012

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study

scientific article published on 27 January 2020

Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing.

scientific article published on 18 December 2011

Organization and ethical aspects of randomized trials in gynecologic oncology

scientific article

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review

scientific article published on 08 November 2019

Orientation of Preclinical Research in Ovarian Cancer

scientific article published in October 2017

Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.

scientific article published on February 2013

Ovarian cancer

scientific article published on 02 October 2006

Ovarian cancer and the immune system

scientific article published on 06 January 2017

Ovarian cancer in children and adolescents: A rare disease that needs more attention

scientific article published on 8 March 2016

Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group

article

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

scientific article published on 08 September 2016

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

scientific article published on 10 September 2019

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

scientific article

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

scientific article published in December 2016

PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.

scientific article published on 27 August 2013

PGF2 alpha levels in breast cancer tissue

scientific article published on 01 November 1984

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas

scientific article published on 01 July 2002

PTEN mutations in uterine sarcomas.

scientific article

Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.

scientific article

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

scientific article published on 01 January 2013

Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging

scientific article

Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy

scientific article published on 19 February 2020

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium

scientific article published on 10 September 2019

Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

scientific article published on 01 August 2019

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

scientific article published on 15 August 2019

Patterns of care in surgery for ovarian cancer in Europe

scientific article published on 30 June 2010

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse

scientific article

Pelvic exenterations for gynecological malignancies: a study of 36 cases.

scientific article published on June 2012

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

scientific article published on 04 March 2006

Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay

scientific article published on 01 November 2011

Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy

scientific article published on 01 September 2005

Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

scientific article

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study

scientific article published on 01 December 2000

Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.

scientific article

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

scientific article published on May 1, 2003

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer

scientific article

Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma

scientific article published on 17 December 2014

Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group

scientific article

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cance

scientific article published on June 2009

Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer

scientific article published on 27 December 2011

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

scientific article

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer

scientific article published on 26 April 2015

Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

scientific article published on 18 February 2020

Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis

scientific article published on 01 January 2011

Placental alkaline phosphatase as a tumor marker in ovarian cancer

scientific article published on 01 February 1987

Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.

scientific article published on 9 October 2012

Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients

scientific article

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

scientific article published on 23 September 2016

Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium

scientific article published on 27 May 2011

Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma

scientific article published on 01 September 2005

Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery

scientific article published on 01 May 2018

Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer

scientific article

Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy

scientific article

Postoperative Evolution of Thickness and Echogenicity of Cutis and Subcutis of Patients With and Without Breast Cancer-Related Lymphedema

scientific article published on 06 February 2014

Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions

scientific article

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors

scientific article

Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer.

scientific article

Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group

scientific article

Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node

scientific article published on 24 April 2014

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium

scientific article

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

scientific article published on 21 November 2012

Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods

scientific article published on May 2007

Preoperative prediction of malignancy of ovarian tumors using least squares support vector machines

scientific article

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing

scientific article published on 01 September 2015

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.

scientific article published on 12 July 2009

Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases

scientific article published on January 12, 2013

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer

scientific article published on September 1, 2011

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?

scientific article published on 01 January 2012

Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course: Glasgow, UK. 3–5 October 2016.

scientific article published on 3 October 2016

Progesterone receptor gene variants and risk of endometrial cancer

scientific article

Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related

scientific article published on 01 June 2006

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer

scientific article published on 31 August 2018

Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide

scientific article published on January 2000

Prognostic factors in stage I ovarian carcinoma.

scientific article published in January 2001

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium

scientific article published on 17 September 2013

Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.

scientific article

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

scientific article published in January 2001

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.

scientific article published on 13 September 2011

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

scientific article published on 6 January 2012

Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data

scientific article

Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosis

scientific article published on September 2014

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial

scientific article

Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?

scientific article published on 13 April 2007

Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia

scientific article published on 01 January 2006

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer

Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data

scientific article

Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome

scientific article published on 12 May 2008

Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer

scientific article published on 01 January 1986

Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS.

scientific article

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.

scientific article

Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125

scientific article published on 01 October 2001

Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report

scientific article published on 01 October 2006

Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study

scientific article published in February 2014

Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients.

scientific article

Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis

scientific article published on 16 August 2010

Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer--Gynecological Cancer Group (EORTC-GCG).

scientific article

Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update

scientific article published on 20 February 2020

Quality of Life Considerations in Gynecologic Cancer

Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

scientific article published on 16 February 2018

Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

scientific article published on November 2006

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

scientific article published on 8 November 2016

Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care

scientific article published on October 2003

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

scientific article published on 27 August 2013

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

scientific article published on 16 September 2010

Radio-immunotargeting in experimental animal models of intraperitoneal cancer

scientific article published on January 1, 1992

Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women

scientific article published on 01 September 2000

Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients

scientific article published on 26 April 2007

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

scientific article published on 23 October 2016

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

scientific article published on July 1, 2010

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

scientific article

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

scientific article published on 25 August 2015

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

scientific article published on 01 March 2000

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

scientific article published on 3 November 2017

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

scientific article

Re: "Comparison of diagnostic usefulness of predictive models in preliminary differentiation of adnexal masses"

scientific article published on 02 February 2007

Re: Mol et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7

scientific article published on 01 October 2001

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

scientific article published in March 2004

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup

scientific article published on 01 September 2000

Reactive nodular fibrous pseudotumor: case report and review of the literature

scientific article published on 30 March 2014

Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways.

scientific article

Reply to B. Freidlin et al.

scientific article

Reply: The performance of the risk of ovarian malignancy algorithm

Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer

scientific article

Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis.

scientific article

Reporting on the results of cancer treatment in patients with metastatic liver disease: proposal of symmetric size-dependent CT-criteria for response

scientific article published in October 1996

Reproducibility of Lymphoscintigraphic Evaluation of the Upper Limb

scientific article published on 21 August 2014

Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center

scientific article published on 23 March 2018

Rhabdomyosarcoma of the corpus of the uterus: a case report

scientific article published on 01 January 2000

Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

scientific article published on 05 February 2019

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

scientific article published on 22 November 2013

Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials

scientific article published in September 2013

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience

scientific article published in November 2015

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort

scientific article published on 13 October 2020

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients

scientific article published in January 2008

Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium

scientific article published in March 2016

Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

scientific article published on 12 August 2019

Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC–IV Ovarian Cancer: Survey Results from the Members of the European Society of Gynecological Oncology

scientific article published on 01 March 2012

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium

scientific article published on 14 September 2012

Role of adnexectomy in the surgical treatment of cervical adenocarcinoma.

scientific article published in September 2005

Role of cyclin-dependent kinase p27 in uterine carcinosarcomas

scientific article published on 01 September 2005

Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

scientific article published on 01 March 2008

Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

scientific article published on 01 April 2009

Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients

scientific article published on 01 September 2006

Role of surgery in ovarian cancer: an update

scientific article published in June 2004

Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer

scientific article published on 06 August 2018

Safety and dose modification for patients receiving niraparib

scientific article published on 01 August 2018

Safety and dose modification for patients receiving niraparib

scientific article published on 01 May 2019

Screening for ovarian carcinoma: not quite there yet

scientific article published on 01 April 2009

Second case of uterine mesonephric adenocarcinoma

scientific article published on May 2006

Second-line lenvatinib in patients with recurrent endometrial cancer

scientific article published on 17 January 2020

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial

scientific article published on 01 August 2020

Sentinel node dissection is safe in the treatment of early-stage vulvar cancer

scientific article published in February 2008

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

scientific article published on 28 September 2015

Sexual and psychological functioning in women after pelvic surgery for gynaecological cancer.

scientific article published in January 2009

Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study

scientific article published on 17 November 2014

Sexual, Psychological, and Relational Functioning in Women After Surgical Treatment for Vulvar Malignancy: A Literature Review

scientific article published on November 14, 2011

Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

scientific article published on 30 July 2015

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors

scientific article published on 16 July 2008

Should tamoxifen users be screened for endometrial lesions?

scientific article published on January 17, 1998

Should we screen for endometrial cancer?

scientific article published on 10 December 2010

Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women

scientific article published on 01 July 2003

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group

scientific article

Simple ultrasound-based rules for the diagnosis of ovarian cancer.

scientific article published in June 2008

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study

scientific article published on 25 May 2010

Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT.

scientific article published in March 1997

Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer

scientific article published on 2 October 2014

Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors

scientific article

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article

Statistical controversies in clinical research: the importance of importance

scientific article published on 6 April 2016

Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up

scientific article published on 29 October 2011

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

scientific article

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

scientific article published on 01 March 2020

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.

scientific article published on 5 January 2012

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience.

scientific article published in January 1999

Successful conservative treatment of endocervical adenocarcinoma stage Ib1 diagnosed early in pregnancy

scientific article published on 01 January 2008

Supervised classification of array CGH data with HMM-based feature selection

scientific article

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Surgery during chemotherapy and at relapse of ovarian cancer

scientific article

Surgical and systemic management of endometrial cancer: an international survey

scientific article published on 15 October 2014

Surgical program building in advanced ovarian cancer: European perspective

scientific article published on August 2009

Surgical treatment of deeply infiltrating endometriosis with colorectal involvement

scientific article published on January 13, 2011

T2-weighted MR imaging of the uterus: comparison of optimized fast spin-echo and HASTE sequences with conventional fast spin-echo sequences

scientific article published on 01 July 1998

Tamoxifen and the uterus

scientific article published on 01 August 1998

Tamoxifen metabolism and efficacy in breast cancer- a prospective multicentre trial

scientific article published on 19 February 2018

Tamoxifen, screening and new oestrogen receptor modulators

scientific article

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.

scientific article published on 7 February 2016

Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group.

scientific article

The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer.

scientific article published on 11 May 2007

The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer

scientific article published in May 2013

The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010).

scientific article published in January 2011

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

scientific article published in July 2015

The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy

scientific article

The Feasibility of Open Laparoscopy in Gynecologic–Oncologic Patients

scientific article published on July 1, 1997

The LACC Trial and Minimally Invasive Surgery in Cervical Cancer

scientific article published on 11 September 2019

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study

scientific article published on 01 February 2011

The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.

scientific article published in November 2016

The addition of 4% oxygen to the CO(2) pneumoperitoneum does not decrease dramatically port site metastases

scientific article published on 01 November 2008

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns

scientific article

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned

scientific article published on 01 November 2004

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer

scientific article published on 15 December 2015

The diagnostic problem of endometrial stromal sarcoma: report on six cases

scientific article

The genetic landscape of 87 ovarian germ cell tumors

scientific article published on 28 August 2018

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype

scientific article published on 17 September 2015

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

scientific article

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women

scientific article published in May 2004

The management of borderline tumours of the ovary

scientific article published on September 2006

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

scientific article published on 07 March 2010

The oestrogen receptor and its selective modulators in gynaecological and breast cancer

scientific article published on 01 September 2000

The position of neoadjuvant chemotherapy within the treatment of ovarian cancer

scientific article published on October 2006

The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers

scientific article published on April 6, 2013

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study

scientific article

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing

scientific article published on 8 March 2011

The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancer

scientific article published on May 2010

The role of interval debulking surgery in ovarian cancer

scientific article published on November 1, 2003

The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.

scientific article published on January 2007

The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen

scientific article published on 20 November 2013

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

scientific article published in February 2003

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study

scientific article

The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.

scientific article

The use of lymph vessel markers to predict endometrial cancer outcome

scientific article published in April 2010

The utility of proteomics in gynecologic cancers

scientific article published on February 2011

The “Leuven” paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study

scientific article published on October 9, 2012

Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model

scientific article published on 01 December 1992

Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

scientific article published in January 2005

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer

scientific article published on 01 September 2006

Timing of debulking surgery in advanced ovarian cancer

scientific article published on March 2008

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

scientific article published on 03 December 2019

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval

scientific article

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial

scientific article

Transition of endometrial stromal sarcoma into high-grade sarcoma.

scientific article published on 21 August 2006

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

scientific article

Treatment algorithm in patients with ovarian cancer

scientific article published on 08 October 2020

Treatment modalities in endometrial cancer

scientific article published on September 2007

Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.

scientific article published on 15 June 2012

Treatment of patients with early epithelial ovarian cancer

scientific article published on November 1, 2003

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium

scientific article published on 28 June 2013

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

scientific article published on 07 May 2019

Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol

scientific article published on 6 March 2012

Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study

scientific article published on 27 July 2018

Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy

scientific article published on 20 May 2019

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT.

scientific article published on 2 October 2015

Ultrasound features of different histopathological subtypes of borderline ovarian tumors

scientific article published on 01 November 2005

Understanding the problem of inadequately staging early ovarian cancer

scientific article published on 13 January 2010

Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas

scientific article

Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer

scientific article

Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study

scientific article published on 01 November 2018

Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.

scientific article published in February 2011

Uterine carcinosarcoma with melanocytic differentiation

scientific article published on 01 April 2001

Uterine rupture due to 15-methylprostaglandin F2 alpha

scientific article published on 01 December 1982

Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations

scientific article

V-Y Bilateral gluteus maximus myocutaneous advancement flap in the reconstruction of large perineal defects after resection of pelvic malignancies

scientific article published on 15 July 2008

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

scientific article published on 17 May 2012

Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

scientific article published on 30 July 2020

Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIB

scientific article published on 03 November 2008

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

scientific article published in PLoS ONE

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

scientific article published on 16 April 2014

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium

scientific article published on 27 February 2019

Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors

scientific article published on July 2015

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

scientific article published on 11 January 2016

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

scientific article

Weekly Paclitaxel-Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma

scientific article published on May 1, 2012

Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer

scientific article published on 01 June 2012

What is the role of dose-dense therapy?

scientific article

What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?

scientific article published on 06 September 2010

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial

scientific article published on 11 July 2013

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

scientific article published on 11 December 2013

Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

scientific article published on 2 September 2016

Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma

scientific article published on February 2011

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

scientific article published in December 2013

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

scientific article

Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study

scientific article published on 22 August 2008

Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies

scientific article published on 02 May 2014

Wilms' tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours

scientific article published in February 2009

ZD9331 in combination with topotecan: phase I and II experience

scientific article published on May 1, 2003

[Epithelial ovarian cancer (advanced stage): consensus conference (1998)]

scientific article published on 01 July 2000

[Prostaglandin F2 alpha, prostacyclin and thromboxane in benign and malignant breast tumors]

scientific article published on 01 January 1987

mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70).

scientific article

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

scientific article published on October 8, 2012

miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients

scientific article published on 04 July 2020

miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study

scientific article published on 05 October 2019

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

scientific article published on 21 August 2018

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

scientific article published on 18 October 2011